Invention Grant
- Patent Title: Antisense nucleic acid that induces skipping of exon 50
-
Application No.: US17847333Application Date: 2022-06-23
-
Publication No.: US11655472B2Publication Date: 2023-05-23
- Inventor: Yukiko Enya , Yuta Sunadoi , Reiko Waki , Kaname Muchima , Shin'ichi Takeda , Yoshitsugu Aoki
- Applicant: NIPPON SHINYAKU CO., LTD. , NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
- Applicant Address: JP Kyoto
- Assignee: NIPPON SHINYAKU CO., LTD.,NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
- Current Assignee: NIPPON SHINYAKU CO., LTD.,NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
- Current Assignee Address: JP Kyoto; JP Kodaira
- Agency: Banner & Witcoff, Ltd.
- Priority: JP 2019236704 2019.12.26
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113 ; A61P21/00 ; A61K31/4965 ; A61K31/7088
Abstract:
The present specification provides a drug that causes highly-efficient skipping of exon 50 in the human dystrophin gene. The present specification provides an antisense oligomer which induces skipping of exon 50 in the human dystrophin gene.
Public/Granted literature
- US20220333112A1 ANTISENSE NUCLEIC ACID THAT INDUCES SKIPPING OF EXON 50 Public/Granted day:2022-10-20
Information query
